Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...

GLP1 drugs are changing patients eating and grocery shopping habits - 2 News Oklahoma's Cathy Tatom hears how from a patient, ...

Data from a Swedish clinic suggests that GLP-1 drugs can be effective in managing severe obesity in children, offering a ...

A new analysis being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), finds that around half of the 100 top ...

In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has gained attention in various research studies ...

In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP ...

These headaches are typically a result of how the drug interacts with your body, not a direct effect of the medication.

Unlike bariatric surgeries, certain body contouring procedures are growing due to GLP-1RA-induced weight loss.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...